QQ客服 官方微博 反馈留言

浏览/检索结果: 共4条，第1-4条 帮助 限定条件 发表日期：2020    内容类型：期刊论文     已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 The Predictive Value of Pre-therapeutic Serum Gamma-glutamyl transferase in Efficacy and Adverse Reactions to Neoadjuvant Chemotherapy among Breast Cancer Patients 期刊论文 JOURNAL OF BREAST CANCER, 2020, 卷号: 23 作者:  Sun, Lu;  Yin, Wenjin;  Wu, Ziping;  Wang, Yaohui;  Lu, Jinsong 收藏  |  浏览/下载：55/0  |  提交时间：2020/12/28 Breast cancer  Gamma-glutamyltransferase  Neoadjuvant therapy  Chemotherapy  Prognosis   Apatinib in treating patients with recurrent or metastatic nasopharyngeal carcinoma who had failed prior platinum-based chemotherapy 期刊论文 TRANSLATIONAL CANCER RESEARCH, 2020, 卷号: 9 作者:  Tao, Chan-Juan;  Zhang, Peng;  Zhou, Ling;  Hu, Qiao-Ying;  Chen, Xiao-Zhong 收藏  |  浏览/下载：20/0  |  提交时间：2020/12/28 Apatinib  nasopharyngeal carcinoma (NPC)  recurrent or metastatic  platinum-based chemotherapy  toxicity   Phase I dose-escalation and expansion study of PARP inhibitor, fluzoparib (SHR3162), in patients with advanced solid tumors 期刊论文 CHINESE JOURNAL OF CANCER RESEARCH, 2020, 卷号: 32, 期号: 3, 页码: 370-+ 作者:  Li, Huiping;  Liu, Rongrui;  Shao, Bin;  Ran, Ran;  Song, Guohong 收藏  |  浏览/下载：22/0  |  提交时间：2020/12/24 Phase I  PARP inhibitor (fluzoparib)  solid tumor  pharmacokinetics  safety  antitumor activity   Extreme-value sampling design is cost-beneficial only with a valid statistical approach for exposure-secondary outcome association analyses 期刊论文 STATISTICAL METHODS IN MEDICAL RESEARCH, 2020, 卷号: 29, 期号: 2, 页码: 466-480 作者:  Zhang, Hang;  Bi, Wenjian;  Cui, Yuehua;  Chen, Honglei;  Chen, Jinbo 收藏  |  浏览/下载：14/0  |  提交时间：2020/05/24 Secondary outcome  exposure  extreme-value sampling design  primary outcome  cost-effective